ELA-11 (human)

ELA-11 (human) Suppliers list
Company Name: Shenzhen Nexconn Pharmatechs Ltd
Tel: +86-755-89396905 +86-15013857715
Email: admin@nexconn.com
Products Intro: Product Name:ELA-11(human)
CAS:1784687-32-6
Purity:98% Package:1KG;10KG;50KG
Company Name: Changsha MOL Changes Biotechnology Co., Ltd.
Tel: +8619375158599
Email: info@molchanges.com
Products Intro: Product Name:ELA-11(human)
CAS:1784687-32-6
Purity:99% Package:5mg;10mg;100mg;1g;10g;100g
Company Name: NANJING YINGWEN BIOTECHNOLOGY CO LTD
Tel: +8613382787392
Email: sales@aeechem.com
Products Intro: CAS:1784687-32-6
Purity:98%
Company Name: BOC Sciences  
Tel: 16314854226
Email: info@bocsci.com
Products Intro: Product Name:ELA-11 (human)
CAS:1784687-32-6
Purity:95% Package:1G;10G;100G Remarks:ELA-11 (human) is a high affinity apelin receptor agonist (Ki = 14 nM). It is a bioactive fragment of ELA-32. ELA-11 (human) inhibits forskolin-induced cAMP production and stimulates β-arrestin recrui
Company Name: Beijing Solarbio Science & Tecnology Co., Ltd.  
Tel: 010-50973130 18101056239
Email: 3193328036@qq.com
Products Intro: Product Name:ELA-11(human)
ELA-11 (human) Basic information
Product Name:ELA-11 (human)
Synonyms:ELA-11 (human);L-Proline, L-cysteinyl-L-methionyl-L-prolyl-L-leucyl-L-histidyl-L-seryl-L-arginyl-L-valyl-L-prolyl-L-phenylalanyl-
CAS:1784687-32-6
MF:C58H90N16O13S2
MW:1283.56
EINECS:
Product Categories:
Mol File:1784687-32-6.mol
ELA-11 (human) Structure
ELA-11 (human) Chemical Properties
density 1.47±0.1 g/cm3(Predicted)
form Solid
pka3.43±0.20(Predicted)
color White to off-white
SequenceCys-Met-Pro-Leu-His-Ser-Arg-Val-Pro-Phe-Pro
Safety Information
MSDS Information
ELA-11 (human) Usage And Synthesis
UsesELA-11(human), a peptide, is a full agonist of human apelin receptor, with a pKi of 7.85. ELA-11(human) completely inhibits Forskolin-induced cAMP production and stimulates β-arrestin recruitment[1].
References[1] Yang P, et, al. Elabela/Toddler Is an Endogenous Agonist of the Apelin APJ Receptor in the Adult Cardiovascular System, and Exogenous Administration of the Peptide Compensates for the Downregulation of Its Expression in Pulmonary Arterial Hypertension. Circulation. 2017 Mar 21;135(12):1160-1173. DOI:10.1161/CIRCULATIONAHA.116.023218
ELA-11 (human) Preparation Products And Raw materials
Tag:ELA-11 (human)(1784687-32-6) Related Product Information